Abstract
In the process of clinical trials and health-care evaluation, Bayesian approaches have increasingly become the center of attention. In this article, sample size calculations for a non-inferiority test of two independent binomial proportions in a clinical trial are considered in a Bayesian framework. The hybrid Neyman-Pearson-Bayesian (hNPB) probability, the conditionally Bayesian (cB) probability and the unconditionally Bayesian (uB) probability are formulated through a conjugate normal analysis. The sample sizes are calculated based on formulas where normal prior distributions are assumed, and are compared with the Neyman-Pearson (NP) sample size. Our results show that the sample size based on the hNPB probability allows us to critically evaluate the appropriateness of the NP sample size. It is suggested that the sample size calculated based on the cB probability formula is smaller than the NP sample size.
TY - JOUR
T1 - Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
A1 - Daimon,Takashi,
Y1 - 2007/12/23/
PY - 2007/07/18/received
PY - 2007/11/21/revised
PY - 2007/12/07/accepted
PY - 2008/1/19/pubmed
PY - 2008/9/16/medline
PY - 2008/1/19/entrez
SP - 507
EP - 16
JF - Contemporary clinical trials
JO - Contemp Clin Trials
VL - 29
IS - 4
N2 - In the process of clinical trials and health-care evaluation, Bayesian approaches have increasingly become the center of attention. In this article, sample size calculations for a non-inferiority test of two independent binomial proportions in a clinical trial are considered in a Bayesian framework. The hybrid Neyman-Pearson-Bayesian (hNPB) probability, the conditionally Bayesian (cB) probability and the unconditionally Bayesian (uB) probability are formulated through a conjugate normal analysis. The sample sizes are calculated based on formulas where normal prior distributions are assumed, and are compared with the Neyman-Pearson (NP) sample size. Our results show that the sample size based on the hNPB probability allows us to critically evaluate the appropriateness of the NP sample size. It is suggested that the sample size calculated based on the cB probability formula is smaller than the NP sample size.
SN - 1559-2030
UR - https://www.unboundmedicine.com/medline/citation/18201944/Bayesian_sample_size_calculations_for_a_non_inferiority_test_of_two_proportions_in_clinical_trials_
L2 - https://linkinghub.elsevier.com/retrieve/pii/S1551-7144(07)00183-8
DB - PRIME
DP - Unbound Medicine
ER -